Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
7.28%
Change (1 year)
Categories
EPS for Xenon Pharmaceuticals (XENE)
EPS in 2023 (TTM): -$2.49
According to Xenon Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.49. In 2022 the company made an earnings per share (EPS) of -$2.04 a decrease over its 2021 EPS that were of -$1.77.
EPS history for Xenon Pharmaceuticals from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.49 | 22.06% |
| 2022 | -$2.04 | 15.25% |
| 2021 | -$1.77 | 117.22% |
| 2020 | -$0.81 | -46.74% |
| 2019 | -$1.53 | -3.16% |
| 2018 | -$1.58 | -7.6% |
| 2017 | -$1.71 | 15.54% |
| 2016 | -$1.48 | 34.55% |
| 2015 | -$1.10 | -218.38% |
| 2014 | $0.93 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | -$3.32 | 33.33% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | -$2.78 | 11.65% | 🇺🇸 USA |